Crossmark

How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study

Crossref DOI link: https://doi.org/10.1186/s12875-018-0856-9

Published Online: 2018-10-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mantelli, Sophie

Jungo, Katharina Tabea

Rozsnyai, Zsofia

Reeve, Emily

Luymes, Clare H.

Poortvliet, Rosalinde K. E.

Chiolero, Arnaud

Rodondi, Nicolas

Gussekloo, Jacobijn

Streit, Sven http://orcid.org/0000-0002-3813-4616
Funding

Funding for this research was provided by:

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (NFP 407440_167465)

SGIM Foundation
License Information

Text and Data Mining valid from 2018-10-12
More Information

Article History

Received: 12 July 2018

Accepted: 3 October 2018

First Online: 12 October 2018

Ethics approval and consent to participate

: The study has been approved by the Ethics Committee of the Canton of Bern (reference number 2017–02188). GPs were informed in writing about the goals of the study and that data would be anonymized. GPs were informed that they were granting consent by clicking to access the survey. The Ethics Committee reviewed and approved this process, which accords with the Swiss Human Research Act (Humanforschungsgesetz, HFG).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.